SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AlienTech who wrote (11294)7/12/1998 6:46:00 PM
From: VLAD  Read Replies (2) of 23519
 
alien,

Whatever it takes to justify their short positions.

Did you ever wonder why Olsziewski set a target of $20.00 within 12
months and Fayemi set a target of $23.00 by years end?

These guys know more about what goes on at Vivus than we would ever hope to know including who might buy out or partner with them.

Notice how in the cc Olsziewski only asked about gene therapy and nothing else--especially nothing regarding international orders or specific cost reductions with the new plant let alone info on a partner or a buy out? He probably already knows about these more important issues so he asks only one question that doesn't have much to do with the situation at hand. So far the info he presented supporting his upgrade has been 100% on target.

The shorts on the other hand foolishly threw a lot of money at Vivus last Friday via BEST and now must do what it takes to bring the price lower if they can. Come Monday let's look carefully at the level II screen and see who is selling and who is buying and how much hiding there is behind INCA ISLD or some of the other separate go it anonymous system. It should be interesting to say the least.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext